Company intelligence / Profile preview

GlycosBio

Houston, Texas, United Statesglycosbio.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

GlycosBio has developed proprietary lipid technologies that enhance the delivery and performance of natural bioactive molecules. Their Activated Oil Systems have been clinically proven for bioavailability, particularly for GI compromised patients.

Therapeutic areas
Gastroenterology
Modalities
Engineered lipid technologiesActivated Oil Systems
Industry
Biotech
02

Drug pipeline

25 assets

GB-NCS-2

Preclinical

24 more assets in the full pipeline.

03

Partnerships

Johnson & Johnson Innovation Center

Beyond the preview

Go deeper on GlycosBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GlycosBio.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call